Ticker Details
Relmada Therapeutics, Inc.
IPO Date:	June 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$302.87M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 3.89%
Avg Daily Range (30 D):	$0.17 | 4.20%
Avg Daily Range (90 D):	$0.17 | 4.62%

Institutional Daily Volume
Avg Daily Volume:	.37M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.88M

Trade Size
Avg Trade Size (Sh.):	141
Avg Trade Size (Sh.) (30 D):	104
Avg Trade Size (Sh.) (90 D):	124

Institutional Trades
Total Institutional Trades:	371
Avg Institutional Trade:	$2.18M
Avg Institutional Trade (30 D):	$3.58M
Avg Institutional Trade (90 D):	$2.61M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.32M
Avg Closing Trade (30 D):	$8.96M
Avg Closing Trade (90 D):	$8.96M
Avg Closing Volume:	118.49K

News

Jul 31, 2025 @ 11:00 AM Relmada Therapeutics to Report Second Quarter 2025... Source: Corporate Communications

Apr 28, 2025 @ 5:38 PM Relmada Therapeutics Presents Positive Initial Pha... Source: N/A

Apr 27, 2025 @ 1:00 PM UPDATE -- Relmada Therapeutics To Present NDV-01 D... Source: N/A

Feb 25, 2025 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight

Dec 9, 2024 @ 12:30 PM Relmada Therapeutics to Discontinue the Reliance I... Source: Globe Newswire

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.3	$-.3	$-.58
Diluted EPS	$-.3	$-.3	$-.58
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-10.09M	$-9.87M	$-17.56M
Operating Income / Loss	$-10.33M	$-10.22M	$-18.22M
Cost of Revenue
Net Cash Flow	$.03M	$-2.5M	$M
PE Ratio

Splits
Sep 30, 2019	1:4
Aug 12, 2015	1:5